Serotonin Receptor Blockers in Ischemic Mitral Regurgitation
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 214 participants.
Also called NCT05469165
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 214 participants
- Registry
-
NCT05469165
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Recruiting
Technical summary
Registry record NCT05469165. Randomized; quadruple masking; primary purpose prevention. Start 2023-06-20 (actual); primary completion 2026-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Serotonin Receptor Blockers in Ischemic Mitral Regurgitation
- Acronym
- CYPRO-MR
- Condition
- Ischemic Mitral Regurgitation
- Intervention (Drug)
- Cyproheptadine 4 Mg Oral Tablet
- Intervention (Other)
- Placebo
- Lead sponsor
- Laval University
- Collaborator
- Canadian Institutes of Health Research (CIHR)
Record details
- Record id
cardio:ct-nct05469165- Content hash
5688f7bab32cd41dbd615d8f78ea2001cebc5e74fb5521221096a024bdeb25fc